| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
3-Deazaadenosine | 6736-58-9 | sc-216428 sc-216428A | 5 mg 10 mg | $357.00 $525.00 | ||
3-Deazaadenosine is a unique nucleoside analog that disrupts the normal function of S-adenosylhomocysteine hydrolase (SAHH) by mimicking adenosine. Its structural modifications lead to altered binding affinities, impacting enzymatic kinetics and substrate specificity. The presence of the nitrogen atom in place of the carbon alters hydrogen bonding patterns, influencing the stability of enzyme-substrate complexes. This compound's distinct electronic properties also affect its reactivity in biochemical pathways, providing insights into nucleoside metabolism. | ||||||
3-Deazaneplanocin, HCl salt | 120964-45-6 | sc-351856 sc-351856A sc-351856B | 1 mg 5 mg 10 mg | $256.00 $612.00 $936.00 | 2 | |
3-Deazaneplanocin, HCl salt, is a potent inhibitor of S-adenosylhomocysteine hydrolase (SAHH), characterized by its unique structural features that enhance its interaction with the enzyme's active site. The presence of a nitrogen atom in its framework modifies the steric and electronic environment, leading to altered reaction kinetics. This compound exhibits distinctive solubility properties, facilitating its engagement in biochemical pathways and influencing metabolic flux. Its ability to form stable complexes with SAHH underscores its role in modulating enzymatic activity. | ||||||
D-Eritadenine | 23918-98-1 | sc-207632 | 10 mg | $233.00 | 6 | |
D-Eritadenine acts as a selective inhibitor of S-adenosylhomocysteine hydrolase (SAHH), distinguished by its unique stereochemistry that promotes specific binding interactions with the enzyme. This compound's structural conformation allows for enhanced affinity, influencing the enzyme's catalytic efficiency. Its dynamic solubility profile aids in its distribution within biological systems, while its capacity to stabilize enzyme-substrate complexes highlights its role in regulating metabolic pathways. | ||||||
Tubercidin | 69-33-0 | sc-258322 sc-258322A sc-258322B | 10 mg 50 mg 250 mg | $184.00 $663.00 $1958.00 | ||
Tubercidin functions as a potent inhibitor of S-adenosylhomocysteine hydrolase (SAHH), characterized by its unique purine-like structure that facilitates strong interactions with the enzyme's active site. Its ability to mimic substrate binding enhances its inhibitory potency, affecting reaction kinetics by altering the enzyme's turnover rate. Additionally, Tubercidin's hydrophilic nature influences its solubility and distribution, impacting its interaction with cellular components and metabolic processes. | ||||||
Adenosine, periodate oxidized | 34240-05-6 | sc-214510 sc-214510A | 25 mg 100 mg | $119.00 $364.00 | ||
Adenosine, periodate oxidized, exhibits distinctive reactivity as a substrate analog for S-adenosylhomocysteine hydrolase (SAHH). Its modified structure enhances electrophilic character, promoting selective interactions with nucleophilic sites in the enzyme. This alteration in molecular configuration influences the enzyme's catalytic efficiency, leading to unique kinetic profiles. Furthermore, its solubility characteristics allow for diverse interactions within biochemical pathways, affecting cellular signaling dynamics. | ||||||
Homocysteine | 6027-13-0 | sc-507315 | 250 mg | $195.00 | ||
Inhibits SAHH by acting as a product feedback inhibitor, leading to reduced SAHH activity due to the accumulation of SAH. | ||||||
Sinefungin | 58944-73-3 | sc-203263 sc-203263B sc-203263C sc-203263A | 1 mg 100 mg 1 g 10 mg | $271.00 $5202.00 $40368.00 $704.00 | 4 | |
Inhibits SAHH through structural similarity to SAH, leading to competitive inhibition of SAHH and subsequent inhibition of the enzyme. | ||||||
Dipyridamole | 58-32-2 | sc-200717 sc-200717A | 1 g 5 g | $31.00 $102.00 | 1 | |
Inhibits SAHH through modulation of adenosine metabolism. Dipyridamole increases extracellular adenosine levels, leading to SAHH inhibition. | ||||||
3-Deazauridine | 23205-42-7 | sc-394445 | 100 mg | $364.00 | 5 | |
Inhibits SAHH through modulation of adenosine metabolism. 3-Deazauridine increases extracellular adenosine levels, leading to SAHH inhibition. | ||||||
Oxipurinol | 2465-59-0 | sc-208138 sc-208138A | 100 mg 500 mg | $222.00 $759.00 | 1 | |
Inhibits SAHH through modulation of adenosine metabolism. Oxipurinol increases extracellular adenosine levels, leading to SAHH inhibition. | ||||||